Ferini-Strambi, Luigi
Sforza, Marco
Galbiati, Andrea
Article History
Received: 22 June 2019
Accepted: 26 June 2019
First Online: 8 July 2019
Compliance with ethical standards
:
: Prof. Luigi Ferini-Strambi received fees from Philips-Respironics, UCB Pharma, Lundbeck, Pfizer, Valeas, Italfarmaco. Dr. Marco Sforza and Dr. Andrea Galbiati have nothing to disclose.
: This study was conducted in accordance with the ethical standards of our Institutional committee on Human experimentation.
: All participants provided written informed consent to the experimental procedure which was previously approved by the local ethical committee.